Innovative therapeutic drug to address unmet needs, including orphan areas
In particular, we will develop drugs for the treatment of high medical needs such as rare diseases (orphan diseases); intractable diseases with few patient, diseases of which treatment has yet been established, and diseases for which no treatment has yet been found. We aim to develop drugs that meet the needs of patients, focusing on disease areas where major pharmaceutical companies have not sufficiently developed therapeutic drugs (there are unmet needs).